Correlation Between Pliant Therapeutics and Immunic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Immunic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Immunic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Immunic, you can compare the effects of market volatilities on Pliant Therapeutics and Immunic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Immunic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Immunic.

Diversification Opportunities for Pliant Therapeutics and Immunic

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pliant and Immunic is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Immunic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunic and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Immunic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunic has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Immunic go up and down completely randomly.

Pair Corralation between Pliant Therapeutics and Immunic

Given the investment horizon of 90 days Pliant Therapeutics is expected to under-perform the Immunic. But the stock apears to be less risky and, when comparing its historical volatility, Pliant Therapeutics is 1.15 times less risky than Immunic. The stock trades about -0.02 of its potential returns per unit of risk. The Immunic is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  121.00  in Immunic on September 1, 2024 and sell it today you would earn a total of  3.00  from holding Immunic or generate 2.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pliant Therapeutics  vs.  Immunic

 Performance 
       Timeline  
Pliant Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Pliant Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Pliant Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Immunic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immunic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pliant Therapeutics and Immunic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pliant Therapeutics and Immunic

The main advantage of trading using opposite Pliant Therapeutics and Immunic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Immunic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunic will offset losses from the drop in Immunic's long position.
The idea behind Pliant Therapeutics and Immunic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Global Correlations
Find global opportunities by holding instruments from different markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital